Last reviewed · How we verify

NCT04015583

Exergaming Improves Executive Functions in Patients With Metabolic Syndrome

Completed NA Last updated 11 July 2019
What this trial tests

NA trial testing exergaming group in Executive Functions in 22 participants. Completed in 31 March 2018.

Timeline
1 April 2017
Primary endpoint
31 December 2017
31 March 2018

Quick facts

Lead sponsorKyoung Im Cho
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment22
Start date1 April 2017
Primary completion31 December 2017
Estimated completion31 March 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Kyoung Im Cho

Who can join

Adults 50 to 80, any sex, with Executive Functions or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Recent studies indicate that exercise-related games can improve executive function, attention processing, and visuospatial skills. Objective: This study investigates whether exercise with exergaming can improve the executive function in patients with metabolic syndrome (MetS). Methods: Twenty-two MetS patients were recruited and randomly assigned to the exergaming group (EXG) and treadmill exercise group (TEG). The reaction time (RT) and electrophysiological signal from the frontal (Fz), central (Cz), and parietal (Pz) cortex were collected during a Stroop task after 12 weeks' exercise.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exergaming Improves Executive Functions in Patients With Metabolic Syndrome: Randomized Controlled Trial.
    Wu S, Jo EA, Ji H, Kim KH, et al · · 2019 · cited 9× · PMID 31368441 · DOI 10.2196/13575

Verify or expand the search:

Other recruiting trials for Executive Functions

Currently open trials in the same condition.

Other Kyoung Im Cho trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04015583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing